Hanife Shariatifar - Kurdistan University of Medical Sciences

Cancer is a major health problem worldwide as the second leading cause of death. Each year, over 10 million new cases and over 5 million deaths from the disease are reported, so it is essential to develop new technologies for accurate early detection and treatment of cancer. Site-specific drug delivery is an important area of research that is anticipated to increase the efficacy of the drug and reduce potential side effects. This manuscript focuses on the work done in the last several years developing gold nanoparticles as cancer therapeutics and diagnostic agents.

Personalized Medicine, Cancer therapy, Gold Nanoparticle, Drug delivery